Nucleic Acids Research Advance Access originally published online on November 14, 2007
Nucleic Acids Research 2007 35(21):7043; doi:10.1093/nar/gkm1015
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2007, Vol. 35, No. 21 7043
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Editorial |
Editorial
CHANGES TO THE CRITERIA FOR CONSIDERATIONIn addition to the general criteria of originality, timeliness, significance and scientific excellence, NAR sets a number of specific Criteria for Consideration in particular subject areas. The aim is to enhance the standards expected for submitted manuscripts in line with scientific developments and to maintain the quality and impact of the journal expected by our readers. Substantial changes and some reorganization have been made recently and the complete Criteria for Consideration may be found at the NAR website at: http://www.oxfordjournals.org/nar/for_authors/criteria_scope.html
Your attention is drawn in particular to new Criteria for:
- Gene Regulation: transcription and RNA processing
- Genome integrity and repair
- RNA functions
- RNA synthetic biology
- Nucleic acid-based delivery systems and reagents for controlling gene expression (e.g. siRNA, miRNA, antisense, ribozymes)
- Natural RNA transcripts (e.g. antisense RNA, miRNA)
Furthermore, we would like to highlight a new initiative:
Chromatin structure and epigenetics
The Journal encourages manuscripts focusing on chromatin and DNA modifications and the mechanisms by which they regulate gene expression, recombination and repair. We give priority to manuscripts that report:
- The identification of novel structural or dynamic features of chromatin, preferably with implications extending beyond a single gene.
- New and general insights into mechanisms that modulate covalent modification of DNA or chromatin proteins. Descriptive studies or reports on variants of well-characterized systems are generally not suitable unless significant new insights are obtained.
Findings should have demonstrated relevance to the native physiological or intracellular context in which the process occurs.
We encourage all authors considering a NAR submission to read the Criteria for Consideration carefully before submitting their manuscripts, so as to reduce the chance of editorial rejection. A direct link to the Scope and Criteria for Consideration is now available from the NAR home page.
CHANGE TO THE SENIOR EUROPEAN EXECUTIVE EDITOR AND SENIOR EUROPEAN EDITORIAL OFFICE
Please note that after 10 years as Senior European Executive Editor, Dr Mike Gait has decided to retire from this role, but he will continue as a regular Editor. From 1 January, 2008, the Senior European Executive Editor will be Professor Keith Fox at the University of Southampton. At the same time, Dr Judy Bradshaw also retires as manager of the Senior European Editorial Office and this role will pass to Dr Martine Bernardes-Silva, who will also be based at the University of Southampton. All enquiries for the Senior European Editorial Office from 1 January, 2008 should be directed to Tel: +44 23 8059 7748 or 4374, Fax: +44 23 8059 7748. Email: nar{at}soton.ac.uk.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||